ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9%
Thu, 9 May

ALEMBIC PHARMA has announced its results for the quarter ended March 2019. Here is a detailed performance review of the same:

ALEMBIC PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Mar-18*
3
Dec-18*
3
Mar-19*
QoQ ChangeYoY Change
Net SalesRs m8,53310,1829,270-9.0%8.6%
Other incomeRs m63534-4.3%426.6%
TurnoverRs m8,54010,2179,303-8.9%8.9%
ExpensesRs m6,8017,7597,489-3.5%10.1%
Gross profitRs m1,7302,4221,783-26.4%3.1%
DepreciationRs m3162913003.1%-5.1%
InterestRs m136051-14.6%279.1%
Profit before taxRs m1,4082,1081,467-30.4%4.2%
TaxRs m385400149-62.8%-61.3%
Profit after taxRs m1,0221,7081,318-22.8%28.9%
Gross profit margin%20.323.819.2
Effective tax rate%27.419.010.2
Net profit margin%12.016.714.2
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 8.6% on a year-on-year (YoY) basis. The expenses were up by 10.1% YoY during the same period.
  • The company's operating profit increased by 3.1% YoY during the quarter. Consequently, operating profit margins witnessed a decline and stood at 19.2% in 4QFY19 as against 20.3% in 4QFY18.
  • Depreciation charges declined by 5.1% and finance costs increased by 279.1% YoY, respectively.
  • Other income increased by 426.6% YoY during the quarter.
  • Net profit for the quarter increased by 28.9% YoY. Net profit margins during the quarter increased from 12.0% in 4QFY18 to 14.2% in 4QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter fell 9.0% on a quarter-on-quarter (QoQ) basis. The expenses were down by 3.5% QoQ during the same period.
  • The company's operating profit declined by 26.4% QoQ during the quarter. Consequently, operating profit margins witnessed a decline and stood at 19.2% in 4QFY19 as against 23.8% in 3QFY18.
  • Net profit for the quarter declined by 22.8% QoQ, while net profit margins declined from 16.7% in 3QFY18 to 14.2% in 4QFY19.

To see how ALEMBIC PHARMA has performed over the last eight quarters, please visit here.

ALEMBIC PHARMA Share Price Performance

Over the last one year, ALEMBIC PHARMA share price has moved up from Rs 500.2 to Rs 540.5, registering a Gain of Rs 40.4 or around 8.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,836.6 (down 0.1%). Over the last one year it has moved up from 13,682.5 to 13,836.6, a gain of 154 points (up 1.1%).

Overall, the S&P BSE SENSEX is up 6.9% over the year.

Current Valuations

At the current price of Rs 540.5, the price to earnings (P/E) ratio of ALEMBIC PHARMA stands at 17.2 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 4.6 times.

Equitymaster requests your view! Post a comment on "ALEMBIC PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 28.9%". Click here!

  

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Jun 13, 2019 | Updated on Jun 13, 2019

Here's an analysis of the annual report of ALEMBIC PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

A Warning for Traders: Don't Get Addicted to Hopium(Fast Profits Daily)

Jun 30, 2020

If you are a trader, you must watch out for this dangerous addiction.

Smallcaps Are in a Sweet Spot Again: Are You Buying?(Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Jul 10, 2020 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA - MYLAN COMPARISON

COMPARE ALEMBIC PHARMA WITH

MARKET STATS